Patents by Inventor Joannes Pol

Joannes Pol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
    Patent number: 7897343
    Abstract: Composition of matter comprising the causative agent of Mystery Swine Disease, Lelystad Agent, in a live, attenuated, dead, or recombinant form, or a part or component of it. Vaccine compositions and diagnostic kits based thereon. Recombinant nucleic acid comprising a Lelystad Agent-specific nucleotide sequence. Peptides comprising a Lelystad Agent-specific amino acid sequence. Lelystad Agent-specific antibodies.
    Type: Grant
    Filed: December 28, 2007
    Date of Patent: March 1, 2011
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Gert Wensvoort, Catharinus Terpstra, Maria Anthonis Joannes Pol, Jacobus Maria Robertus Moormann, Jacoba Maria Johanna Meulenberg
  • CAUSATIVE AGENT OF THE MYSTERY SWINE DISEASE, VACCINE COMPOSITIONS AND DIAGNOSTIC KITS
    Publication number: 20080108107
    Abstract: Composition of matter comprising the causative agent of Mystery Swine Disease, Lelystad Agent, in a live, attenuated, dead, or recombinant form, or a part or component of it. Vaccine compositions and diagnostic kits based thereon. Recombinant nucleic acid comprising a Lelystad Agent-specific nucleotide sequence. Peptides comprising a Lelystad Agent-specific amino acid sequence. Lelystad Agent-specific antibodies.
    Type: Application
    Filed: December 28, 2007
    Publication date: May 8, 2008
    Inventors: Gert WENSVOORT, Catharinus Terpstra, Joannes Pol, Robertus Moormann, Johanna Meulenberg
  • Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
    Publication number: 20050058655
    Abstract: Composition of matter comprising the causative agent of Mystery Swine Disease, Lelystad Agent, in a live, attenuated, dead, or recombinant form, or a part or component of it. Vaccine compositions and diagnostic kits based thereon. Recombinant nucleic acid comprising a Lelystad Agent-specific nucleotide sequence. Peptides comprising a Lelystad Agent-specific amino acid sequence. Lelystad Agent-specific antibodies.
    Type: Application
    Filed: July 14, 2004
    Publication date: March 17, 2005
    Inventors: Gert Wensvoort, Catharinus Terpstra, Joannes Pol, Robertus Moormann, Johanna Meulenberg